| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/10/2002 | US6448027 Method for specific measurement of acid phosphatase derived from osteoclasts |
| 09/10/2002 | US6448025 Motor proteins and methods for their use |
| 09/10/2002 | US6448023 A method for cancer screening by detecting sphingosine 1 phosphate (s1p) in a patient comprising: reacting a patient sample with a first enzyme to cleave s1p into a mixture of ethanolamine-1-phospate and long-chain aldehyde; measuring the |
| 09/10/2002 | US6448021 Cc-chemokine receptor 2 (ccr2) bound by an antibody or functional fragment to block binding of a ligand |
| 09/10/2002 | US6448019 Inhibit vascular smooth muscle cell activation and/or proliferation or enhance vascular endothelial cell activation and/or proliferation or activate estrogen responsive genes in vascular cells. vasoprotective agents are vasospecific, |
| 09/10/2002 | US6448017 In vitro amplification of nucleic acid molecules via circular replicons |
| 09/10/2002 | US6448016 The invention provides purified and isolated dna fragments from bacillus anthracis chromosomal dna, primer sets and probes derived therefrom, as well as kits and detection methods for b. anthracis. the methods of the invention provide |
| 09/10/2002 | US6448015 Probe for detecting point mutations in DNA utilizing fluorescence energy transfer |
| 09/10/2002 | US6448014 PCR-hybridization assays specific for integrated retroviruses |
| 09/10/2002 | US6448013 Quantitatively determining the amount of polynucleotides in a sample. the distinct polynucleotide targets and standard polynucleotide targets are contacted with detectable probes and independently detectable single or double stranded |
| 09/10/2002 | US6448012 Method for mapping a nucleic acid |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | US6448010 Detecting a mutation in a target nucleic acid sequence that comprises attaching oligonucleotide primers to a substrate, wherein the oligonucleotide primers have a sequence that is complementary to the target nucleic acid sequence, and wherein |
| 09/10/2002 | US6448007 Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elements |
| 09/10/2002 | US6448006 Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents |
| 09/10/2002 | US6448005 14723 Receptor, a novel G-protein coupled receptor |
| 09/10/2002 | US6448004 Electrochemiluminescence helicase assay |
| 09/10/2002 | US6448003 An isolated stp2 polynucleotide comprising a nucleic acid sequence selected from the group consisting of: a nucleic acid sequence comprising at least 12 contiguous nucleotides of a nucleic acid sequence selected from the group consisting of |
| 09/10/2002 | US6448002 Method to detect clinically relevant mutations of the DNA sequence of ki-ras oncogene, its use and a testkit for early diagnosis of tumors |
| 09/10/2002 | US6448001 Analytical method, kit, and apparatus |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447999 Tthe combination of two mechanisms of detection in a single device yields a method which allows the simple quantification of analyte determinations. |
| 09/10/2002 | US6447998 Method of detecting the presence, absence or amount of a particular dna duplex in a sample suspected of containing dna comprising contacting the sample with an oligomer of under conditions wherein a triple helix is formed between the |
| 09/10/2002 | US6447997 Gene coding for GADD153 as a clinical diagnostic and prognostic in cancer therapy |
| 09/10/2002 | US6447996 Polypeptides having galanin receptor activity, genetic material for expressing same, any recombinant cell expressing said polypeptides, and the use thereof, are disclosed. |
| 09/10/2002 | US6447993 Protecting cats from infection by a broad range of fiv strains using a multi-subtype fiv vaccine. multi-subtype fiv vaccines comprising either cell free whole virus or cell lines infected with viruses and vaccinating cats |
| 09/10/2002 | US6447990 Cleaning validation studies of medical devices (including narrow lumened flexible endoscopes and other difficult to clean medical devices) is described. testing for adequate cleaning/rinsing has been performed on the medical device. |
| 09/10/2002 | US6447804 Dry solid medium for storage and analysis of genetic material |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447776 Monoclonal antibodies against mutant amino acid sequences generated by genetic deletions or point mutations; detection of cancer |
| 09/10/2002 | US6447771 Methods and materials relating to novel CD39-like polypeptides |
| 09/10/2002 | US6447764 Method for isolating anionic organic substances from aqueous systems using cationic polymer nanoparticles |
| 09/10/2002 | CA2219895C Selection of livestock using igf levels |
| 09/10/2002 | CA2073441C Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 09/09/2002 | CA2375276A1 Methods to isolate gene coding and flanking dna |
| 09/09/2002 | CA2340308A1 The process of identification of mutations that control the ability of viruses to replicate and cause disease and the application of these mutations to viral diagnosis and antiviral therapy |
| 09/08/2002 | CA2370324A1 Large circular target-specific antisense nucleic acid compounds |
| 09/06/2002 | WO2002068962A2 Determining cartilage degeneration and aging using bone morphogenic proteins |
| 09/06/2002 | WO2002068957A1 Microcavity biosensor, methods of making, and uses thereof |
| 09/06/2002 | WO2002068955A1 Transgenic knockouts of bace-1 |
| 09/06/2002 | WO2002068932A2 Methods for providing extended dynamic range in analyte assays |
| 09/06/2002 | WO2002068931A2 Screening for enzyme stereoselectivity utilizing mass spectrometry |
| 09/06/2002 | WO2002068927A2 Using viruses to detect or purify proteins |
| 09/06/2002 | WO2002068699A1 Cytotoxic t-lymphocyte antigen-4 or interleukin-10 polymorphisms as predictors of response to therapeutic intervention |
| 09/06/2002 | WO2002068697A2 Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems |
| 09/06/2002 | WO2002068696A2 Methods for dna conjugation onto solid phase including related optical biodiscs and disc drive systems |
| 09/06/2002 | WO2002068695A2 Quantitative immunohistochemistry (qihc) |
| 09/06/2002 | WO2002068694A1 Differentially methylated sequences in pancreatic cancer |
| 09/06/2002 | WO2002068692A1 Methods for improving or altering promoter/enhancer properties |
| 09/06/2002 | WO2002068691A1 Methods for identifying ligand binding sites in a biomolecule |
| 09/06/2002 | WO2002068689A1 Method of detecting mitochondrial dysfunction |
| 09/06/2002 | WO2002068687A2 Function and application of tob gene in central nervous system of mammal |
| 09/06/2002 | WO2002068686A1 Methods for analysis of rna |
| 09/06/2002 | WO2002068685A2 Diagnostic test for the detection of chromosomal abnormalities in a fetus |
| 09/06/2002 | WO2002068684A2 Allele-specific primer extension assay |
| 09/06/2002 | WO2002068683A2 Circular probe amplification (cpa) using energy-transfer primers |
| 09/06/2002 | WO2002068682A2 Method for identifying biologically active structures of microbial pathogens |
| 09/06/2002 | WO2002068680A2 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |
| 09/06/2002 | WO2002068679A2 Determining the risk of caries in a patient |
| 09/06/2002 | WO2002068678A2 Beta-lactamase substrates having phenolic ethers |
| 09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | WO2002068672A2 Antisense modulation of recql4 expression |
| 09/06/2002 | WO2002068663A1 Tau-opathy model |
| 09/06/2002 | WO2002068656A1 Nucleic acids coding for a protein interacting with a porin channel |
| 09/06/2002 | WO2002068645A2 Compositions and methods relating to breast specific genes and proteins |
| 09/06/2002 | WO2002068635A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 09/06/2002 | WO2002068633A2 Compositions and methods relating to lung specific genes and proteins |
| 09/06/2002 | WO2002068630A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | WO2002068628A1 70 human secreted proteins |
| 09/06/2002 | WO2002068623A2 Genes encoding proteolytic enzymes from aspargilli |
| 09/06/2002 | WO2002068618A1 Methods for monitoring protease inhibitor antiretroviral therapy |
| 09/06/2002 | WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | WO2002068613A1 Biosynthesis of polyketide synthase substrates |
| 09/06/2002 | WO2002068605A2 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | WO2002068603A2 Materials and methods for the induction of premature chromosome condensation |
| 09/06/2002 | WO2002068597A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068589A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068583A2 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | WO2002068580A2 Integrated filtration and detection device |
| 09/06/2002 | WO2002068579A2 Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
| 09/06/2002 | WO2002068537A2 Fluorescent dye |
| 09/06/2002 | WO2002068473A1 Biosensor for detecting chemical agents |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068466A2 Hypoxia-regulated genes |
| 09/06/2002 | WO2002068452A2 Method of isolating charged compounds, especially peptides and proteins |
| 09/06/2002 | WO2002068451A2 Sperm protein 17 for the diagnosis and treatment of cancer |
| 09/06/2002 | WO2002068448A1 Method for evaluating the ability to metabolize pharmaceuticals and compositions therefor |
| 09/06/2002 | WO2002068446A1 Antisense modulation of talin expression |
| 09/06/2002 | WO2002068445A1 Antisense nucleic acid inhibitors of mycothiol production in mycobacterium tuberculosis |
| 09/06/2002 | WO2002068444A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 09/06/2002 | WO2002067984A2 Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection |
| 09/06/2002 | WO2002067868A2 Methods for the treatment of metabolic disorders, including obesity and diabetes |
| 09/06/2002 | WO2002067860A2 Selection by mirror image display |
| 09/06/2002 | WO2002067857A2 Modified annexin proteins and methods for preventing thrombosis |
| 09/06/2002 | WO2002067848A2 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE |
| 09/06/2002 | WO2002067771A2 Chemokine receptors and disease |
| 09/06/2002 | WO2002067764A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 09/06/2002 | WO2002048674A3 Methods, devices, arrays and kits for detecting and analyzing biomolecules |
| 09/06/2002 | WO2002048182A3 Interferon-alpha induced gene |
| 09/06/2002 | WO2002046415A9 Polynucleotide and polypeptide sequences of putative transporters and ion channells |